- Home
- DNTH vs SPFI Comparison
DNTH vs SPFI Comparison
Compare DNTH & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- SPFI
- Stock Information
- Founded
- DNTH 2015
- SPFI 1941
- Country
- DNTH United States
- SPFI United States
- Employees
- DNTH N/A
- SPFI N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- SPFI Major Banks
- Sector
- DNTH Health Care
- SPFI Finance
- Exchange
- DNTH Nasdaq
- SPFI Nasdaq
- Market Cap
- DNTH 711.2M
- SPFI 647.7M
- IPO Year
- DNTH N/A
- SPFI 2019
- Fundamental
- Price
- DNTH $23.80
- SPFI $35.83
- Analyst Decision
- DNTH Strong Buy
- SPFI Buy
- Analyst Count
- DNTH 9
- SPFI 2
- Target Price
- DNTH $46.43
- SPFI $33.50
- AVG Volume (30 Days)
- DNTH 203.7K
- SPFI 35.9K
- Earning Date
- DNTH 11-07-2024
- SPFI 01-24-2025
- Dividend Yield
- DNTH N/A
- SPFI 1.68%
- EPS Growth
- DNTH N/A
- SPFI N/A
- EPS
- DNTH N/A
- SPFI 2.56
- Revenue
- DNTH $5,366,000.00
- SPFI $183,911,000.00
- Revenue This Year
- DNTH $98.73
- SPFI N/A
- Revenue Next Year
- DNTH N/A
- SPFI $6.18
- P/E Ratio
- DNTH N/A
- SPFI $13.98
- Revenue Growth
- DNTH 51.41
- SPFI N/A
- 52 Week Low
- DNTH $8.24
- SPFI $24.05
- 52 Week High
- DNTH $33.77
- SPFI $40.91
- Technical
- Relative Strength Index (RSI)
- DNTH 46.14
- SPFI 39.80
- Support Level
- DNTH $22.59
- SPFI $38.55
- Resistance Level
- DNTH $24.57
- SPFI $39.49
- Average True Range (ATR)
- DNTH 1.49
- SPFI 1.51
- MACD
- DNTH 0.04
- SPFI -0.51
- Stochastic Oscillator
- DNTH 30.84
- SPFI 50.00
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has two reportable segments: banking and insurance.